KNSA
Price
$20.08
Change
-$0.41 (-2.00%)
Updated
Dec 18, 04:59 PM (EDT)
69 days until earnings call
MDXXF
Price
$0.17
Change
-$0.00 (-0.00%)
Updated
Dec 18 closing price
Ad is loading...

KNSA vs MDXXF

Header iconKNSA vs MDXXF Comparison
Open Charts KNSA vs MDXXFBanner chart's image
Kiniksa Pharmaceuticals International
Price$20.08
Change-$0.41 (-2.00%)
Volume$3.93K
CapitalizationN/A
PharmAla Biotech Holdings
Price$0.17
Change-$0.00 (-0.00%)
Volume$76.73K
CapitalizationN/A
KNSA vs MDXXF Comparison Chart
Loading...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDXXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KNSA vs. MDXXF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KNSA is a Hold and MDXXF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (KNSA: $20.06 vs. MDXXF: $0.17)
Brand notoriety: KNSA and MDXXF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KNSA: 138% vs. MDXXF: 123%
Market capitalization -- KNSA: $1.48B vs. MDXXF: $16.25M
KNSA [@Biotechnology] is valued at $1.48B. MDXXF’s [@Biotechnology] market capitalization is $16.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KNSA’s FA Score shows that 1 FA rating(s) are green whileMDXXF’s FA Score has 0 green FA rating(s).

  • KNSA’s FA Score: 1 green, 4 red.
  • MDXXF’s FA Score: 0 green, 5 red.
According to our system of comparison, KNSA is a better buy in the long-term than MDXXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KNSA’s TA Score shows that 4 TA indicator(s) are bullish while MDXXF’s TA Score has 4 bullish TA indicator(s).

  • KNSA’s TA Score: 4 bullish, 4 bearish.
  • MDXXF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both KNSA and MDXXF are a good buy in the short-term.

Price Growth

KNSA (@Biotechnology) experienced а -5.60% price change this week, while MDXXF (@Biotechnology) price change was -17.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.11%. For the same industry, the average monthly price growth was -2.34%, and the average quarterly price growth was +0.25%.

Reported Earning Dates

KNSA is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KNSA($1.48B) has a higher market cap than MDXXF($16.3M). MDXXF YTD gains are higher at: 429.430 vs. KNSA (16.819).
KNSAMDXXFKNSA / MDXXF
Capitalization1.48B16.3M9,074%
EBITDA-24.4MN/A-
Gain YTD16.819429.4304%
P/E Ratio164.54N/A-
Revenue384MN/A-
Total Cash224MN/A-
Total Debt10.6MN/A-
FUNDAMENTALS RATINGS
KNSA: Fundamental Ratings
KNSA
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
51
SMR RATING
1..100
89
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KNSAMDXXF
RSI
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 15 days ago
88%
Declines
ODDS (%)
Bearish Trend 8 days ago
80%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDXXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TVC22.730.01
+0.04%
Tennessee Valley Authority Power Bonds 1998 Series D due June 1 2028
TTAI29.99N/A
N/A
FCF International Quality ETF
CTEC7.05-0.02
-0.23%
Global X CleanTech ETF
FLQL60.73-0.25
-0.41%
Franklin US Large Cap Mltfctr Idx ETF
CMDT26.01-0.11
-0.42%
PIMCO Commodity Strategy Act Exc-Trd Fd

KNSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with ABVC. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then ABVC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
+0.84%
ABVC - KNSA
40%
Loosely correlated
-5.59%
NTLA - KNSA
39%
Loosely correlated
-1.87%
FATE - KNSA
38%
Loosely correlated
-6.00%
AMRN - KNSA
36%
Loosely correlated
-0.80%
BEAM - KNSA
35%
Loosely correlated
-1.21%
More

MDXXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXXF has been loosely correlated with NICXF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXXF jumps, then NICXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXXF
1D Price
Change %
MDXXF100%
-4.07%
NICXF - MDXXF
46%
Loosely correlated
N/A
ABVC - MDXXF
25%
Poorly correlated
-5.59%
ZIVO - MDXXF
23%
Poorly correlated
-20.65%
KNSA - MDXXF
20%
Poorly correlated
+0.84%
VYGR - MDXXF
20%
Poorly correlated
-3.55%
More